Getting started with the ID Tablet
2287B EN 20191031
Agfa NV, Septestraat 27, B-2640 Mortsel, Belgium
1
Intended Use
The ID Tablet is a device for the transfer of data from the
NX modality workstation to AGFA CR cassettes. This data
links the image recorded on the cassette to the patient
study selected on the NX modality workstation.
2
Installation
The installation and configuration of the ID Tablet is
performed by the local Agfa service organization and/or
Agfa dealer.
on/off switch
3
Operating controls
The ID Tablet can be switched on (green light illuminated)
and off using the switch on the front side of the ID Tablet.
4
Using the ID Tablet
Insert a cassette in the ID Tablet as shown below.
Inserting CR MD or CR MM
cassette
Inserting CR MD 3.0, CR
MD4.xR, CR HD5.x, CR
HM5.x, CR MM3.0, CR
MM3.xR, CR MD4.xT, CR
MD4.2 Extremities or CR
MM3.xT cassette
In the Examination
window, select the right
thumbnail in the Image
Overview.
Click ID or press F2.
The thumbnail is labelled with the code ‘ID’. The patient
data is written to the cassette.
Make the exposure.
It is advised to identify the cassette before the exposure
to avoid mix-up of exposed, unidentified cassettes.
5
Product complaints
Any health care professional (for example a customer or a
user) who has any complaints or has experienced any
dissatisfaction with the quality, durability, reliability,
safety, effectiveness, or performance of this product must
notify Agfa.
For a patient/user/third party in the European Union and
in countries with identical regulatory regimes (Regulation
2017/745/EU on Medical Devices); if, during the use of
this device or as a result of its use, a serious incident has
occurred, please report it to the manufacturer and/or its
authorised representative and to your national authority.
Manufacturer address:
Agfa Service Support - local support addresses and phone
numbers are listed on www.agfa.com
Agfa - Septestraat 27, 2640 Mortsel, Belgium
Agfa - Fax +32 3 444 7094
6
Safety precautions
WARNING: Strictly observe all warnings,
cautions, notes and safety markings within
this document and on the product.
WARNING: Safety is only guaranteed when
trained Agfa personnel have installed the ID
Tablet.
WARNING: All Agfa medical products must be
used by Agfa trained and qualified personnel.
WARNING: Although the device is tested
against applicable standards for EMC and
short range devices, there is a residual risk of
interference with other electronic devices.
WARNING: Although all system components
are tested during manufacturing, the ID tablet
may fail to detect /write/ read the data of an
inserted cassette. Try to solve the problem by
restarting the ID Tablet.
CAUTION: Position the Agfa product so that it
is possible to disconnect the mains power
connection if required.
CAUTION: Changes, additions or maintenance
to the Agfa products carried out by persons
